Cargando…
Inhibition of cotranslational translocation by apratoxin S4: Effects on oncogenic receptor tyrosine kinases and the fate of transmembrane proteins produced in the cytoplasm
Receptor tyrosine kinases (RTKs) have become major targets for anticancer therapy. However, resistance and signaling pathway redundancy has been problematic. The marine-derived apratoxins act complementary to direct kinase inhibitors by downregulating the levels of multiple of these receptors and ad...
Autores principales: | Cai, Weijing, Ratnayake, Ranjala, Wang, Mengxiong, Chen, Qi-Yin, Raisch, Kevin P., Dang, Long H., Law, Brian K., Luesch, Hendrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663948/ https://www.ncbi.nlm.nih.gov/pubmed/34909679 http://dx.doi.org/10.1016/j.crphar.2021.100053 |
Ejemplares similares
-
Improved Total Synthesis and
Biological Evaluation
of Potent Apratoxin S4 Based Anticancer Agents with Differential Stability
and Further Enhanced Activity
por: Chen, Qi-Yin, et al.
Publicado: (2014) -
Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor Activity
por: Chen, Qi-Yin, et al.
Publicado: (2011) -
Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2
and Exhibits Broad-Spectrum Antiviral Activity
por: Pohl, Marie O., et al.
Publicado: (2022) -
Identification of cytoplasmic residues of Sec61p involved in ribosome binding and cotranslational translocation
por: Cheng, Zhiliang, et al.
Publicado: (2005) -
Apratoxin chaperones EGFR to its destruction
por: Short, Ben
Publicado: (2009)